Credit: CC0 Public Domain The final results are in for MOMENTUM 3, the largest left-ventricular assist device (LVAD) trial ever conducted. The study of more than 1,000 patients with severe heart failure not only confirms that the HeartMate 3, a next-generation LVAD device, markedly reduced the need for re-operations due to pump malfunctions, but also […]Continue Reading ...
Among first-time users of a new insulin pump that automatically delivers insulin to people with type 1 diabetes, nearly one-fifth stopped using the device, primarily because of difficulties meeting the technical demands system, researchers say. Results of a real-world study of the hybrid closed loop insulin pump (Medtronic MiniMed 670G) will be presented Sunday at […]Continue Reading ...
Severely ill patients with advanced heart failure who received a novel heart pump—the HeartMate 3 left ventricular assist device (LVAD)— suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology’s 68th […]Continue Reading ...
The U.S. Food and Drug Administration today permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes. This new type of insulin pump, referred to as an alternate controller enabled (ACE) infusion pump, or ACE insulin […]Continue Reading ...
Dec 18 2018 Rapid controlled transport of water droplets by sunlight-powered pump Driven by natural or artificial sunlight, a novel “microtube pump” transports water droplets over long distances. As reported by Chinese researchers in the Journal Angewandte Chemie, the pump consists of a tube whose properties can be changed asymmetrically through irradiation. This results in […]Continue Reading ...
June 5, 2018 In a presentation at the annual meeting of the Heart Failure Association of the European Society of Cardiology, and in a simultaneous publication in Circulation, investigators from Brigham and Women’s Hospital presented evidence that a next-generation cardiac pump device not only improves long-term outcomes but may also decrease cost of care over […]Continue Reading ...
March 12, 2018 New findings, presented today at the American College of Cardiology, provide long-term information about survival, stroke rates and durability of a novel centrifugal-flow pump compared with a commercial axial flow pump for heart-failure patients. BWH investigators report that patients who received the centrifugal-flow pump had significantly lower rates of pump-related blood clots […]Continue Reading ...
How can I make pumping more straightforward? As with nursing, it’s a must to be at ease when pumping (which does not all the time appear imaginable when you are connected to a gadget). It may be arduous, particularly to start with, to your frame (and your thoughts) to get used to generating milk with out […]Continue Reading ...
The final results are in for MOMENTUM 3, the largest left-ventricular assist device (LVAD) trial ever conducted. The study of more than 1,000 patients with severe heart failure not only confirms that the HeartMate 3™, a next-generation LVAD device, markedly reduced the need for re-operations due to pump malfunctions, but also found that it lowered […]Continue Reading ...
Credit: CC0 Public Domain Two children from Europe and one from Canada, aged four, six and 10, suffer from a previously unknown disease that causes epileptic seizures, loss of magnesium and reduced intelligence. There is currently no way to treat or alleviate their symptoms. But researchers in an international consortium have now discovered the cause […]Continue Reading ...
Most insulin pumps are about the size of a small mobile phone, but models keep getting smaller. They are mostly worn on the body using a band, belt, pouch, or clip. Some models now are wireless. Traditional pumps include an insulin reservoir (cartridge) and a catheter. The catheter is inserted with a plastic needle just […]Continue Reading ...
Nov 29 2018 The new VARODRY is a 100% oil-free, dry compressing screw vacuum pump. Screw pumps are currently state-of-the-art in the field of industrial vacuum pumps. The VARODRY will initially be available in the sizes VD65 (65 m³/h) and VD100 (100 m³/h), the sizes VD160 and VD200 are already in preparation. What qualifies the […]Continue Reading ...
May 16, 2018 Breast milk has many known health benefits, but breastfeeding is not always an option for moms, and many turn to pumping as an alternative. Katherine Hornbostel, assistant professor of mechanical engineering and materials science at the University of Pittsburgh Swanson School of Engineering, wanted to make this often cumbersome process easier. She […]Continue Reading ...
March 12, 2018 At two years of follow-up, severely ill patients with advanced heart failure who received a novel heart pump fully implantable within the chest experienced no malfunctions requiring replacement or removal of the device for blood clotting. Further, their risk of a stroke was halved compared with patients who received the established version […]Continue Reading ...
(HealthDay)—5 years after coronary-artery bypass grafting (CABG) surgical treatment, sufferers whose operation used to be carried out with cardiopulmonary bypass (on pump) lived longer than the ones whose surgeons carried out the process with out cardiopulmonary bypass (off pump), in line with a record revealed within the Aug. 17 factor of the New England Magazine […]Continue Reading ...
- New gene therapy cures babies with fatal ‘Bubble Boy’ disease
- No female mice? Scientists may still approve NIH grant
- What needs to be said about mental health in medicine
- Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
- Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
- Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
- Adhesive gel bonds to eye surface, could repair injuries without surgery
- The future of genomics: A podcast featuring Stanford geneticists
- As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
- APOE gene impacts sleep depending on gender and severity of Alzheimer’s
- PCORI’s newly approved awards focus on cancer pain and opioid use disorders
- New tool provides a standard way to measure effects of caring for survivors of TBI
- Smartphone use risks eye examination misdiagnosis
- How drug-resistant bugs grow in CF patients’ lungs
- Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
- Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
- Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
- New estimation method assesses natural variations in sex ratio at birth
- UTA scientist receives $1.17 million grant for cancer research
- Coagulation factor VIIa prevents bleeds in hemophilia animal models